Dutch sample and assay technology expert Qiagen has continued its march into the detection system market with the acquisition of Biotage’s Biosystems business.
Biotage has announced plans to shift its business focus to the
environmental analysis sector - an industry on the rise as soaring
world population demands more efficient and safe laboratory
technologies to deal with waste, hazardous...
Biotage has acquired exclusive rights to an evaporation technology,
which substantially reduces sample-drying time for pharmaceutical
chemists, meeting the need to relieve a major bottleneck in
chemistry and drug development.
Sweden's Biotage, a specialist in microwave synthesis and
chromatography systems for drug development and production, has
taken some of its European distribution into its own hands through
the purchase of Separtis Holding.
Sweden's Biotage has launched a system for carrying out microwave
synthesis reactions that for the first time is targeted at the
individual medicinal chemist.
Sweden's Pyrosequencing has entered into an agreement to buy
prification and separation specialist Biotage, a subsidiary of Dyax
of the USA, for $35 million.